Modifier Gene Studies to Identify New Therapeutic Targets in Cystic Fibrosis

E-ISSN： 1873-4286|18|5|674-682

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.5, 2012-02, pp. : 674-682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic potential of the human cystic fibrosis transmembrane conductance regulator gene

By Pavirani A.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. : 1187-1192

Informa Healthcare

Access to resources Recommend Favorite

Enviromimetics: exploring gene environment interactions to identify therapeutic targets for brain disorders

By McOmish Caitlin E Hannan Anthony J

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 899-913

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for cystic fibrosis

By Boyd A.C.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 1, 2001-01 ,pp. : 1-15

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for cystic fibrosis

By Kitson C. Alton E.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1523-1535

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for cystic fibrosis

By Conese Massimo Gioia Sante Di Castellani Stefano

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 8, 2008-08 ,pp. : 929-943

Informa Healthcare

Access to resources Recommend Favorite